Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Pediatrics

Long-Term Monitoring and Life with IGS

At a Glance

Children with Imerslund-Gräsbeck syndrome need lifelong vitamin B12 replacement and follow-up. Care includes blood tests, kidney checks even when protein remains in the urine, monitoring growth and neurological health, and planning for independent adult care.

Living with Imerslund-Gräsbeck syndrome (IGS) means shifting your focus to the long-term rhythm of maintaining health. While IGS is a lifelong condition, regular care helps manage it [1]. Your child’s medical team will use a combination of laboratory tests and clinical check-ups to ensure their body and brain have the Vitamin B12 they need.

The Rhythm of Long-Term Monitoring

Monitoring for IGS involves tracking symptoms, physical exams, and lab values.

  • Blood Tests: Your doctor will likely order a Complete Blood Count (CBC) to monitor red blood cells, along with Vitamin B12 levels [2]. They may also check Methylmalonic Acid (MMA) and Homocysteine, which can rise when B12 stores dip [3].
  • Interpreting the Numbers: It is important to know that a single serum B12 value can be misleadingly high shortly after an injection, and that MMA and homocysteine can be affected by other factors like kidney function or folate levels. Treatment dose changes should not be based on a single B12 number alone, but rather interpreted alongside your child’s clinical picture and kidney health.
  • The Kidney Check: Because the protein reabsorption mechanism in the kidneys remains broken, your child will continue to have proteinuria (protein in the urine) even after they are healthy [4][5]. Published reports generally show preserved kidney function over time, but long-term data is limited [6][7]. Doctors will periodically check creatinine and eGFR to confirm the kidneys are filtering waste properly [7][5]. Contact your team promptly if you notice new swelling, blood in the urine, high blood pressure, or reduced urine output.
  • Growth and Development: Your pediatrician will track your child’s growth (height, weight/BMI) and their progress in reaching learning and motor milestones [7][8].

What to Expect as Your Child Grows

For most children, the primary goal of long-term care is preventing a relapse of deficiency.

  • Neurocognitive Health: With early B12 replacement, neurological symptoms generally improve [1][9]. Regular check-ups will include neurological assessments to check coordination and strength [9][8]. However, some residual neurological effects can persist depending on the severity of the initial deficiency.

Preparing for the Future: Transition to Adult Care

As your child grows, the goal of care shifts toward independence. This process, often called transition, should be individualized based on your child’s readiness [10].

  • Taking Charge: Over time, your child will learn how to schedule appointments and perhaps manage their own injections [11][12].
  • Lifelong Adherence: One of the biggest challenges in adulthood is staying consistent with treatment when feeling perfectly healthy [7]. Because IGS symptoms develop slowly, a person might skip injections for months before realizing they are in trouble. Encouraging your child to see their Vitamin B12 as routine care helps ensure they stay healthy for decades to come.

Common questions in this guide

How often should a child with IGS have vitamin B12 and related blood tests?
The schedule depends on the child's age, weight, treatment plan, symptoms, and clinical findings, so the medical team should set it individually. Doctors may follow a complete blood count, vitamin B12, methylmalonic acid, and homocysteine, but a single B12 result should not determine dose changes, especially soon after an injection.
What does persistent protein in the urine mean for a child with IGS?
Protein in the urine can continue because the kidney reabsorption problem remains even after vitamin B12 deficiency is treated. Published reports generally describe preserved kidney function, but long-term information is limited. The care team can follow creatinine and estimated glomerular filtration rate (eGFR) to check how well the kidneys filter waste.
Which changes could signal a kidney problem in a child with IGS?
Contact the care team promptly if your child develops new swelling, blood in the urine, high blood pressure, or much less urine than usual. These changes need medical assessment rather than being attributed to the usual protein in the urine.
How is my child's growth and neurological development followed in IGS?
Routine visits may track height, weight or body mass index, learning progress, and motor milestones. Neurological checks can assess coordination and strength; early vitamin B12 replacement generally improves neurological symptoms, although some effects may persist depending on the severity of the initial deficiency.
When should a child with IGS start learning to manage their own care?
Transition to adult care should be individualized and based on the child's readiness rather than a single age. Gradually learning to schedule visits, track injections, and eventually give injections can build independence, while regular vitamin B12 treatment remains important even when the child feels well.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my child's current age and weight, how often should we be testing their B12, MMA, and homocysteine levels?
  2. 2.Since the protein in the urine may not go away, what specific kidney function tests (like eGFR) will be performed to ensure their kidneys stay healthy?
  3. 3.Are there specific developmental or learning milestones we should watch more closely as my child enters school?
  4. 4.At what age will we start the transition process to adult care, and how will you help my child learn to manage their own injections?
  5. 5.Is a formal neurological exam part of our regular follow-up schedule to monitor for any subtle changes in coordination or strength?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (12)
  1. 1

    Imerslund-Gräsbeck syndrome: a comprehensive review of reported cases.

    Kingma SDK, Neven J, Bael A, et al.

    Orphanet journal of rare diseases 2023; (18(1)):291 doi:10.1186/s13023-023-02889-x.

    PMID: 37710296
  2. 2

    Imerslund-Gräsbeck syndrome in a child with a novel compound heterozygous mutations in the AMN gene: a case report.

    Zhang D, Liu S, Xi B, et al.

    Italian journal of pediatrics 2024; (50(1)):191 doi:10.1186/s13052-024-01757-z.

    PMID: 39334390
  3. 3

    Inherited defects of cobalamin metabolism.

    Watkins D, Rosenblatt DS

    Vitamins and hormones 2022; (119()):355-376 doi:10.1016/bs.vh.2022.01.010.

    PMID: 35337626
  4. 4

    Clinical and molecular characteristics of imerslund-gräsbeck syndrome: First report of a novel Frameshift variant in Exon 11 of AMN gene.

    Elshinawy M, Gao HH, Al-Nabhani DM, Al-Thihli KA

    International journal of laboratory hematology 2021; (43(5)):1009-1015 doi:10.1111/ijlh.13473.

    PMID: 33491342
  5. 5

    [Clinical analysis of two brothers with Imerslund-Gräsbeck syndrome].

    Xi WW, Cao L, Huo HL, et al.

    Zhonghua yi xue za zhi 2021; (101(40)):3351-3354 doi:10.3760/cma.j.cn112137-20210709-01537.

    PMID: 34758537
  6. 6

    Benign proximal tubular albuminuria due to AMN mutation: A challenging presentation of Imerslund-Gräsbeck syndrome.

    Pul S, Güven S, Çiçek N, et al.

    Pediatric nephrology (Berlin, Germany) 2026; (41(4)):999-1001 doi:10.1007/s00467-025-07052-1.

    PMID: 41236624
  7. 7

    Profound vitamin D deficiency in four siblings with Imerslund-Grasbeck syndrome with homozygous CUBN mutation.

    Ciancio JIR, Furman M, Banka S, Grunewald S

    JIMD reports 2019; (49(1)):43-47 doi:10.1002/jmd2.12072.

    PMID: 31497480
  8. 8

    A child with Imerslund-Gräsbeck syndrome concealed by co-existing α-thalassaemia presenting with subacute combined degeneration of the spinal cord: a case report.

    Arunath V, Hoole TJ, Rathnasri A, et al.

    BMC pediatrics 2021; (21(1)):41 doi:10.1186/s12887-021-02499-1.

    PMID: 33461510
  9. 9

    Acute cerebellar ataxia as the first manifestation of Imerslund-Gräsbeck syndrome.

    Eslamiyeh H

    Iranian journal of child neurology 2021; (15(4)):105-108 doi:10.22037/ijcn.v15i4.27482.

    PMID: 34782847
  10. 10

    Pediatric to Adult Hydrocephalus: A Smooth Transition.

    Hong MA, Sukumaran A, Riva-Cambrin J

    Neurology India 2021; (69(Supplement)):S390-S394 doi:10.4103/0028-3886.332245.

    PMID: 35102994
  11. 11

    Health care transition from pediatric to adult care: an evidence-based guideline.

    Pape L, Ernst G

    European journal of pediatrics 2022; (181(5)):1951-1958 doi:10.1007/s00431-022-04385-z.

    PMID: 35084548
  12. 12

    Childhood to adult transition in youth patients with lysosomal acid lipase deficiency: 43 recommendations from experts.

    Hermida-Ameijeiras A, Blasco-Alonso J, Carrillo-Linares JL, et al.

    Orphanet journal of rare diseases 2025; (20(1)):337 doi:10.1186/s13023-025-03852-8.

    PMID: 40604916

This page is for informational purposes only and does not replace professional medical advice. Your child's healthcare team should interpret monitoring results and guide vitamin B12 treatment.

Get notified when new evidence is published on Imerslund-Gräsbeck syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.